Thrombin-mediated activation of factor XI results in a thrombin- activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis

Journal of Clinical Investigation

Volumn 99, Issue 10, 1997, Pages 2323-2327

  Von Dem Borne, Peter A Kr ^a   Bajzar, Laszlo ^b   Meijers, Joost C M ^a   Nesheim, Michael E ^c   Bouma, Bonno N ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF VERMONT   (United States)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

carboxypeptidase; coagulation; Factor XI; fibrinolysis; thrombin

Indexed keywords

3 (2 GUANIDINOETHYL) 2 MERCAPTOSUCCINIC ACID; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 11A; CARBOXYPEPTIDASE B; ENZYME PRECURSOR; THROMBIN;

ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING; ENZYME ACTIVATION; FIBRIN FORMATION; FIBRINOLYSIS; HUMAN; PRIORITY JOURNAL; THROMBIN TIME;

EID: 0030962331     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119412     Document Type: Article

References (26)

1. Naito, K., and K. Fujikawa. 1991. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J. Biol. Chem. 266: 7353-7358.
2. Gailani, D., and G.J. Broze. 1991. Factor XI activation in a revised model of blood coagulation. Science (Wash. DC). 253:909-912.
3. von dem Borne, P.A.K., S.J. Koppelman, B.N. Bouma, and J.C.M. Meijers. 1994. Surface independent factor XI activation by thrombin in the presence of high molecular weight kininogen. Thromb. Haemostasis. 72:397-402.
4. Gailani, D., and G.J. Broze. 1993. Factor XII-independent activation of factor XI in plasma: effects of sulfatides on tissue Factor-induced coagulation. Blood. 82:813-819.
5. von dem Borne, P.A.K., J.C.M. Meijers, and B.N. Bouma. 1995. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood. 86:3035-3042.
6. Asakai, R., D.W. Chung, E.W. Davie, and U. Seligsohn. 1991. Factor XI deficiency in Ashkenazi Jews in Israel. N. Engl. J. Med. 325:153-158.
7. Bajzar, L., R. Manuel, and M.E. Nesheim. 1995. Purification and characterization of TAFI, a thrombin activatable fibrinolysis inhibitor. J. Biol. Chem. 270:14477-14484.
8. Comp, P.C., and C.T. Esmon. 1981. Generation of fibrinolytic activity by infusion of activated protein C into dogs. J. Clin. Invest. 68:1221-1228.
9. Sakata, Y., D.J. Loskutoff, C.L. Gladson, C.M. Hekman, and J.H. Griffin. 1986. Mechanism of protein-C dependent clot lysis: role of plasminogen activator inhibitor. Blood. 68:1218-1223.
10. de Fouw, N.J., F. Haverkate, and R.M. Bertina. 1990. Protein C and fibrinolysis: a link between coagulation and fibrinolysis. Adv. Exp. Med. Biol. 281:235-243.
11. Bajzar, L., J.C. Fredenburgh, and M.E. Nesheim. 1990. The activated protein C-mediated enhancement of tissue-type plasminogen activator-induced fibrinolysis in a cell-free system. J. Biol. Chem. 265:16948-16954.
12. Bajzar. L., and M.E. Nesheim. 1993. The effect of activated protein Con fibrinolysis in cell free plasma can be attributed specifically to attenuation of prothrombin activation. J. Biol. Chem. 268:8608-8616.
13. Eaton, D.L., B.E. Malloy, S.P. Tsai, W. Henzel, and D. Drayna. 1991. Isolation, molecular cloning and partial characterization of a novel carboxypeptidase B from human plasma. J. Biol. Chem. 266:21833-21838.
14. Folk, J.E., and J.A. Gladner. 1960. Carboxypeptidase B. IV. Purification and characterization of the porcine enzyme. J. Biol. Chem. 235:2272-2278.
15. Hendriks, D., W. Wang. S. Scharpé, M.P. Lommaert, and M. van Sande. 1990. Purification and characterization of a new arginine carboxypeptidase in human serum. Biochim. Biophys. Acta. 1034:86-92.
16. Wang, W., D.F. Hendriks, and S.S. Scharpé. 1994. Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen. J. Biol. Chem. 269:15937-15944.
17. Pannell, R., J. Black, and V. Gurewich. 1988. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained. J. Clin. Invest. 81:853-859.
18. Miles, L.A., C.M. Dahlberg, J. Plescia, J. Felez, K. Kato, and E.F. Plow. 1991. Role of cell-surface lysines in plasminogen binding to cells: identification of α-enolase as a candidate plasminogen receptor. Biochemistry. 30:1682-1691.
19. Redlitz, A., A.K. Tan, D.L. Eaton, and E.F. Plow. 1995. Plasma carboxypeptidases as regulators of the plasminogen system. J. Clin. Invest. 96:2534-2538.
20. van der Graaf, F., J.S. Greengard, B.N. Bouma, D.M. Kerbiriou, and J.H. Griffin. 1983. Isolation and functional characterization of the active light chain of activated human blood coagulation factor XI. J. Biol. Chem. 258:9669-9675.
21. Meijers, J.C.M. 1988. Regulation of the blood coagulation mechanism by plasma proteinase inhibitors. Ph.D. thesis. State University of Utrecht, The Netherlands. 93-108.
22. Bajzar, L., M.E. Nesheim, and P.B. Tracy. 1996. The pro-fibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent. Blood. 88:2093-2100.
23. Kisiel, W., K.J. Smith, and B.A. McMullen. 1985. Proteolytic inactivation of blood coagulation factor IX by thrombin. Blood. 66:1302-1308.
24. Broze, G.J., Jr., and D.A. Higuchi. 1996. Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma. Blood. 88:3815-3823.
25. Kessels. H., S. Béguin, H. Andree, and H.C. Hemker. 1994. Measurement of thrombin generation in whole blood. The effect of heparin and aspirin. Thromb. Haemostasis. 72:78-83.
26. Bajzar, L., J. Morser, and M. Nesheim. 1995. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J. Biol. Chem. 271:16603-16608.